Assistant Professor
Vanderbilt University Medical Center
Dr. Stephanie Rolsma is an assistant professor in the Division of Pediatric Infectious Diseases at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Dr. Rolsma has experience in microbiology, vaccine development, and clinical research and her current research focuses on therapeutics and interventions in critically ill patients and clinical trials. Her primary research focuses on evaluating the utility of therapeutic drug monitoring of beta-lactam antibiotics in pediatric and adult patients, including cystic fibrosis patients and patients receiving intensive critical care and cardiac support and renal replacement therapy. She also serves as a sub-investigator with her mentor, Dr. Buddy Creech, in studies conducted through the NIH-funded Vanderbilt Vaccine and Treatment Evaluation Unit (VTEU), including Moderna and Janssen Phase 3 SARS-CoV-2 vaccine trials in adults, a Moderna Phase 2/3 SARS-CoV-2 vaccine trial in children, a Moderna Phase 1 SARS-CoV-2 variant vaccine trial in adults, a study of infant immune responses to RSV, and an intranasal influenza vaccine in pediatric patients. As a co-investigator for the CDC-funded Clinical Immunization Safety Assessment Network, she works to address safety issues and clinical adverse events following vaccinations. She has successfully applied for fellowship funding support through the Childhood Infection Research Program NIH T32 Award, the David T. Karzon Fellowship in Pediatric Infectious Diseases, the Vanderbilt Institute for Clinical and Translational Research, and the Infectious Diseases Clinical Research Consortium New Investigator Pilot Award.
Dr. Rolsma received her B.S. in Microbiology from Michigan State University. She was awarded a Ph.D. in Microbiology and Molecular Genetics and M.D. from the Medical College of Wisconsin, where she was a part of the Medical Scientist Training Program. She completed a residency in pediatrics and a fellowship in pediatric infectious diseases at Monroe Carell Jr. Children’s Hospital at Vanderbilt.